You are here

• Home
• Therapy Areas
• Neuroscience

• The purpose of this study is to assess the safety and effect of TC-5214 as a single therapy in patients with major depressive disorder who exhibit inadequate response to antidepressants.

Disease

depressive disorder

Drug Name

TC-5214

Generic Name

TC-5214

Sponsor

AstraZeneca

Drug Status

Discontinued

Phase

II

Start Date

Feb 5, 2011

Study Name

D4131C00001

Study Id

D4131C00001

ClinicalTrials.gov ID

NCT01288079

Recruiting Status

Closed

Protocol Status

Not Available

Report

Jul 30, 2012

• D4131C00001.pdf (463 KB)

Page tools

• Print
• Bookmark this page